Examples of using Tolerability in English and their translations into Japanese
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
-
Programming
Depending on the clinical response and tolerability of the individual patient, the dose may be adjusted within the range of 150 to 750 mg per day.
Safety and tolerability profile of sorafenib was generally consistent with the known profile of sorafenib.
The safety and tolerability profile of BIIB059 supports its continued development, and Biogen plans to advance BIIB059 to Phase 3.
Biogen reported that“the safety and tolerability profile of BIIB059 supports its continued development.”.
The safety and tolerability profile in this analysis supports continued development of BIIB067 in ALS.
The clinical and metabolic tolerability of CMA has been demonstrated in numerous clinical studies with duration of treatment of up to 2.5 years.
The safety and tolerability of the treatment triplet was as expected and did not show any new or unexpected toxicities.
Depending on the clinical response and tolerability in each patient, the dose can be specified in the range of 150 to 750 mg/ day.
Depending on the clinical response and tolerability of the individual patient, the dose may be adjusted within the range 150 to 750 mg/day.
Due to their excellent blood pressure-lowering effects and high tolerability, dihydropyridine calcium antagonists are now the leading antihypertensive agents in Japan.
Depending on the clinical effect and the tolerability of the drug, its dose can individually vary from 150 to 750 mg/ day.
The safety and tolerability profile of BIIB059 supports its continued development.
These monoclonal antibodies can determine a reduction in cholesterol levels higher than 50% with an excellent safety and tolerability profile.
When poor tolerability daily dose can be divided into 2 reception/ administration.
It is characterized by a fairly high positive outlook, low incidence of complications, and good tolerability.
The patient was compliant during all the procedure and clearly commented on much higher tolerability as compared to the LIO.
The drug, with better tolerability, produce fewer side effects in a subject and/or patient in comparison to the medicine having more poor tolerability.
The primary outcome was safety and tolerability of NTCD-M3 within 7 days of treatment.
In a clinical study conducted to support this application, the drug has shown efficacy, safety and tolerability.
There were no treatment-related Grade 3 or Grade 4 adverse events, and no withdrawals from the trial for tolerability.